Gambia tightens rules for Indian meds after cough syrup deaths - letter

Indonesia Berita Berita

Gambia tightens rules for Indian meds after cough syrup deaths - letter
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 trtworld
  • ⏱ Reading Time:
  • 36 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 63%

After suffering 70 child deaths linked to cough syrup imported from India, The Gambia will make it mandatory for all pharmaceutical products from the country to be inspected and tested prior to shipment

Seventy children died in the Gambia last year after ingesting cough syrup made in India. Now the Gambia is taking steps to "address issues related to substandard and falsified medicines entering the country".Grieving parents hold up signs during a news conference, calling for justice for the deaths of children linked to contaminated cough syrups, in Serekunda, Gambia, November 4, 2022.

The new rule highlights how governments are reassessing their reliance on India's $42 billion pharmaceutical industry since the contamination came to light last year. India's industry supplies nearly half of the pharmaceuticals used in Africa. In April, India’s government said its officials had held meetings in Africa to ensure its drug exports did not suffer after at least 70 children died in the Gambia after ingesting the cough syrup last year.

The letter said that the MCA had appointed Quntrol Laboratories, an independent inspection and testing company for pharmaceuticals based in Mumbai, to issue a Clean Report of Inspection and Analysis for all shipments from India.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

trtworld /  🏆 101. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Drug Shortages Stem From Quality Problems in Indian FactoriesDrug Shortages Stem From Quality Problems in Indian FactoriesShoddy conditions at factories in India have sickened Americans and stoked a chemotherapy-drug shortage for cancer patients, raising calls for a more-resilient generic-drug supply.
Baca lebih lajut »

Indian police retain carrier pigeons as backstop against disastersIndian police retain carrier pigeons as backstop against disastersEven in today's world of instant messaging, video calls, the internet and mobile telephones, police in India's eastern state of Odisha are preserving a flock of carrier pigeons for use when disasters sever communication links.
Baca lebih lajut »

18 Stunning Indian Bridal Hairstyles Curated By Bollywood Hairstylists18 Stunning Indian Bridal Hairstyles Curated By Bollywood HairstylistsFrom flower-adorned updos to high-shine waves, there is a style here for everyone.
Baca lebih lajut »

Elon Musk scheduled to meet Indian Prime Minister Modi on TuesdayElon Musk scheduled to meet Indian Prime Minister Modi on TuesdayMusk and Modi are expected to discuss Tesla's ambitions in the country, setting up a manufacturing base and possible incentives for battery production.
Baca lebih lajut »

USD/INR Price Analysis: 200-DMA prods Indian Rupee sellers around 82.10USD/INR Price Analysis: 200-DMA prods Indian Rupee sellers around 82.10USD/INR renews intraday high near 82.10 as it prints three-day uptrend while bouncing off the key support line amid early Tuesday in Europe. The India
Baca lebih lajut »

Breakingviews - Mega-merger gives Indian lender new lease on lifeBreakingviews - Mega-merger gives Indian lender new lease on lifeIndia’s financial sector is poised to have a refurbished champion. HDFC Bank , the country’s largest private lender, is set in July to complete its merger with its parent, partner and 26% shareholder Housing Development Finance Corporation (HDFC) . The institution run by Sashidhar Jagdishan will sport a market value of some $140 billion and become a mortgage giant in a credit-starved market. It’s an enticing prospect for foreign investors, with some big caveats.
Baca lebih lajut »



Render Time: 2025-02-27 22:14:01